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Hematopoietic stem cells (HSCs) and their lympho-
hematopoietic progeny are supported by microenvi-
ronmental niches within bone marrow; however, the
identity, nature, and function of these niches remain
unclear. Short-term ablation of CXC chemokine
ligand (CXCL)12-abundant reticular (CAR) cells
in vivo did not affect the candidate niches, bone-
lining osteoblasts, or endothelial cells but severely
impaired the adipogenic and osteogenic differentia-
tion potential of marrow cells and production of the
cytokines SCF and CXCL12 and led to a marked
reduction in cycling lymphoid and erythroid progen-
itors. HSCs from CAR cell-depleted mice were
reduced in number and cell size, were more quies-
cent, and had increased expression of early myeloid
selector genes, similar to the phenotype of wild-type
HSCs cultured without a niche. Thus, the niche com-
posed of adipo-osteogenic progenitors is required
for proliferation of HSCs and lymphoid and erythroid
progenitors, as well as maintenance of HSCs in an
undifferentiated state.
INTRODUCTION
Hematopoietic stem cells (HSCs) give rise to all lineages of blood
cells, including immune cells in the bone marrow. It has been
assumed that the special microenvironments known as niches
play an essential role in maintaining HSCs and hematopoietic
progenitors in the marrow to provide appropriate numbers of
mature blood cells throughout life (Morrison and Spradling,
2008; Wilson and Trumpp, 2006). HSCs and lymphoid progeni-
tors are thought to reside in their niches, and the identity of
the niche has been a subject of longstanding debate. It has
been shown that HSCs are in contact with a population of
osteoblasts lining the bone surface, termed spindle-shaped
N-cadherin+CD45 osteoblastic (SNO) cells, which expressIma high amount of N-cadherin (endosteal niches) (Zhang et al.,
2003). In contrast, many HSCs are associated with sinusoidal
endothelium, suggesting that endothelial cells create cellular
niches for HSCs (vascular niches) (Kiel et al., 2005). We have
shown that CXCR4, a primary receptor for the CXC chemokine
ligand (CXCL)12 (also known as stromal cell-derived factor-1)
(Nagasawa, 2006; Nagasawa et al., 1996; Nagasawa et al.,
1994; Tachibana et al., 1998; Zou et al., 1998), is essential for
maintaining a pool of HSCs and B cells and that most HSCs,
early B cell precursors, and plasma cells are scattered
throughout the bone marrow cavity and are in contact with
a small population of reticular cells with long processes,
expressing high amounts of CXCL12, called CXCL12-abundant
reticular (CAR) cells, suggesting that CAR cells are a key compo-
nent of niches for both HSCs and B cells (Nagasawa, 2008;
Sugiyama et al., 2006; Tokoyoda et al., 2004). However,
these studies do not reveal the functions of SNO cells, endothe-
lial cells, and CAR cells as niches for HSCs and/or lymphoid
progenitors.
Prior studies using a variety of gain-of-function and loss-of-
function approaches examined the identity and functions of
cellular niches for HSCs and hematopoietic progenitors. Bone
morphogenetic protein (BMP) receptor type IA (BMPRIA) condi-
tionally deficient mice displayed increases in the numbers of
SNO cells, which correlated with an increase in the numbers of
HSCs (Zhang et al., 2003). Parathyroid hormone (PTH) adminis-
tration increased the numbers of osteoblasts in culture and
induced an increase in the number of HSCs in vivo (Calvi et al.,
2003). In contrast, it has been shown that depleting osteoblastic
lineage cells with a 2.3 kb fragment from the rat type I collagen a1
(Col1a1) gene promoter driving thymidine kinase (Col2.3DTK)
induced a marked reduction in hematopoietic cells (Visnjic
et al., 2004; Zhu et al., 2007). These results suggest that osteo-
blastic lineage cells maintain HSCs and hematopoietic cells
but do not rule out the possibility that Col1a1, BMPRIA, and
PTH or PTH-related protein receptor (PPR) are expressed in
bone marrow reticular cells, including CAR cells. In addition,
it has been reported that reductions in osteoblasts do not neces-
sarily lead to reductions in HSCs and hematopoietic cells (Kiel
et al., 2007; Wilson and Trumpp, 2006). Together, it remains
unresolved which cell types play major roles in regulating themunity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc. 387
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marrow.
It is assumed that most adult HSCs are quiescent and that
HSC quiescence is maintained by their niches (Arai et al.,
2004; Orford and Scadden, 2008). In contrast, many studies
have shown that the majority of HSCs are cycling, albeit slowly,
although some HSCs are highly dormant, (Cheshier et al., 1999;
Foudi et al., 2009; Santaguida et al., 2009; Wilson et al., 2008;
Yamazaki et al., 2006) and that many lineage-restricted progen-
itors are known to be cycling actively, supporting the idea that
HSC and hematopoietic progenitor proliferation is maintained
by their niches. However, the technology to prove this was lack-
ing and the role of niches in controlling the quiescence, prolifer-
ation, and differentiation of HSCs and lymphoid progenitors
remain unclear. Here, we generated mice that allow selective
ablation of CAR cells in bone marrow and determined the nature
and in vivo function of CAR cells as a niche for HSCs and lym-
pho-hematopoietic progenitors.
RESULTS
Generation of Mice that Allow Inducible Selective
Ablation of CAR Cells In Vivo
To determine the nature and in vivo function of CAR cells, we
generated mice in which a transgene encoding the Diphtheria
toxin (DT) receptor-green fluorescent protein (DTR-GFP) fusion
protein (Saito et al., 2001) was knocked into the Cxcl12 locus
(CXCL12-DTR-GFP mice) (Figure 1A). These mice allow the
conditional ablation of CXCL12-expressing cells by DT adminis-
tration because wild-typemurine cells are insensitive to killing by
DT (Saito et al., 2001). CXCL12-DTR-GFP mice were injected
intraperitoneally (i.p.) with DT at a dose of 25 ng/kg; many mice
remained healthy for up to 3 days after injection and died
5 days after injection probably from liver failure. By histological
analysis, the liver of CXCL12-DTR-GFP mice showed necrosis
and haemorrhage at 5 days after DT treatment but appeared
normal at 2 days after DT treatment. Histological analysis of
bone marrow microenvironments 2 or 3 days after DT treatment
revealed that CXCL12-DTR-GFP+ CAR cells were eliminated or
severely reduced, but bone-lining SNO cells, osteocalcin+ or
marked alkaline phosphatase (ALP) activity-containing osteo-
blasts, and sinusoidal endothelial cells remained unaffected in
DT-treated CXCL12-DTR-GFP mice compared with untreated
CXCL12-DTR-GFP mice (Figures 1B and 1C; Figure S1 available
online; data not shown). Flow-cytometric analysis confirmed that
the numbers of CXCL12-DTR-GFPhi CAR cells were severely
reduced in DT-treated CXCL12-DTR-GFP mice compared with
untreated animals (Figure 1E). In addition, consistent with the
result that CAR cells are a small population of VCAM-1+ reticular
cells (Tokoyoda et al., 2004), many VCAM-1+ reticular cells were
observed in DT-treated and untreated CXCL12-DTR-GFP mice
(Figure 1D).
Short-Term Ablation of CAR Cells Leads to a Reduction
in Cycling Lymphoid and Erythroid Progenitors
To better define the direct effect of CAR cell depletion on hema-
topoiesis, we examined the effect of short-term ablation of CAR
cells on hematopoietic cells in the bone marrow using CXCL12-
DTR-GFP mice 2 days after DT treatment, in which CAR cells388 Immunity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc.were eliminated or severely reduced. Total bone marrow cellu-
larity was reduced in DT-treated CXCL12-DTR-GFP mice
compared with DT-treated and untreated wild-type mice
(Figure 2A and Figure S2A). Flow-cytometric analysis of hemato-
poietic progenitors revealed that although the numbers of
Lineage(Lin)Sca-1+c-kit+Flt3+ multipotent progenitors (MPPs)
(Adolfsson et al., 2001) appeared normal, LinIL-7Ra+Flt3+
common lymphoid progenitors (CLPs) (Karsunky et al., 2008)
and c-kit+CD71+Ter119lo proerythroblasts were almost absent,
the numbers of c-kit+CD19+IgM pro-B cells and LinSca-1
c-kit+CD34FcgRII-IIIlo megakaryocyte and erythrocyte progen-
itors (MEPs) (Akashi et al., 2000) were severely reduced and the
number of LinSca-1c-kit+CD34+FcgRII-IIIhi granulocyte and
macrophage progenitors (GMPs) (Akashi et al., 2000) was
more modestly reduced in DT-treated CXCL12-DTR-GFP mice
compared with untreated CXCL12-DTR-GFPmice or DT-treated
and untreated wild-type mice (Figures 2B and 2C and
Figure S2A). Cell-cycle analysis of pro-B cells and MEPs using
Pyronin Y (PY) revealed that around half of the cells were cycling
actively (high PY fluorescence [PYhi]) and other quiescent cells
displayed low PY fluorescence (PYlo) in DT-treated wild-type
mice. In contrast, a reduction in the frequency of PYhi cells and
an increase in the frequency of PYlo cells were observed in
DT-treated CXCL12-DTR-GFP mice (Figure 2D). Additionally,
Annexin-V staining of pro-B cells revealed many apoptotic cells
(43%) in DT-treated CXCL12-DTR-GFP mice although few
(5.1%) were detected in DT-treated wild-type mice (Figure 2E).
These results indicate that CAR cells are essential for lymphoid,
erythroid, and myeloid lineage development and suggest that
CAR cells support the survival and proliferation of B cell progen-
itors and proliferation of erythroid progenitors.
HSCs Are Reduced and More Quiescent in the Absence
of CAR Cells
We next examined the effect of short-term ablation of CAR cells
on HSCs. Bone marrow from CXCL12-DTR-GFP and wild-type
mice was analyzed 2 days after DT treatment. The number of
CD34LinSca-1+c-kit+CD150+CD48 cells, which are highly
enriched for long-term repopulating HSCs (Foudi et al., 2009;
Kiel et al., 2005; Wilson et al., 2008), was reduced, but to a lesser
extent than lymphoid and erythroid progenitors in DT-treated
CXCL12-DTR-GFP mice compared with control animals
(Figure 3A and Figure S3A). Because the unambiguous measure
of HSCs is long-term transplantation, we estimated the numbers
of HSCs using repopulating units (RU), based on a competitive
repopulation assay (Harrison et al., 1993). The numbers of RU
were reduced about 50% in the bone marrow of CXCL12-DTR-
GFP mice compared with wild-type mice (Figure 3B), indicating
that CAR cells play an essential role in maintaining the HSC
number.
Flow-cytometric analysis using the proliferation marker Ki67
has shown that a small percentage of CD34LinSca-1+
c-kit+CD48 HSCs express Ki67 in DT-treated or untreated
wild-type mice, as reported previously, but the numbers of
Ki67-positive cells were severely reduced in the HSC population
from DT-treated CXCL12-DTR-GFP mice (Figure 3C). Quantita-
tive, real-time polymerase chain reaction with reverse transcrip-
tion (qRT-PCR) analysis revealed that the mRNA expression of
Evi-1 and Pbx1, which are essential for HSC maintenance and
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Figure 1. Short-Term Selective Ablation of CAR Cells In Vivo in Bone Marrow
(A) Strategy used to generate CXCL12-DTR-GFP mice. C, Csp45I; Xh, XhoI; Xb, XbaI; N, NotI. Triangles represent LoxP sites.
(B–E) Bone marrow from CXCL12-DTR-GFP mice was analyzed 2 days after administration of DT or control vehicle. Bone marrow sections were stained with
antibodies against GFP, N-cadherin, the panendothelial marker PECAM-1 (CD31) (B), and VCAM-1 (D) and assayed by Fast Red staining (C). CXCL12-DTR-
GFP+ CAR cells (green) are eliminated (B, left); however, bone-lining SNO cells detected by anti-N-cadherin antibodies (B, arrowheads; red), marked ALP
activity-containing osteoblasts (C, arrowheads; red), and sinusoidal endothelial cells (B, right; blue) exhibit normal numbers and morphology in DT-treated
CXCL12-DTR-GFPmice. The nuclei of cells were labeled with DAPI dye (B, right; white). (E) Flow cytometric analysis of CD45Ter119CD31 nonhematopoietic
cells. The numbers of CXCL12-DTR-GFPhi CAR cells per two femurs and tibiae are shown (E, right). All error bars represent SD of the mean. n = 4; *p < 0.05.
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Roles of Adipo-osteoprogenitors as the BM Nichepreferentially expressed in HSCs (Ficara et al., 2008; Goyama
et al., 2008), was largely unaffected in the HSC population from
DT-treated CXCL12-DTR-GFP mice (Figure 3D and Figure S3C).
In contrast, although cell-cycle-promoting genes, includingImthose that encode Cyclin D1, D2, A2, and their catalytic partner,
Cdc2a, and a regulator of initiation of DNA replication, Cdc6,
were expressed in the HSC population from DT-treated and
untreated wild-type mice and untreated CXCL12-DTR-GFPmunity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc. 389
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Figure 2. Essential In Vivo Functional Roles
of CAR Cells in Lympho-hematopoietic
Progenitors
Bone marrow from wild-type and CXCL12-DTR-
GFP mice was analyzed by flow cytometry
2 days after DT administration.
(A) Total numbers of CD45+ hematopoietic cells
per two femurs and tibiae. n = 3; *p < 0.05.
(B) Immunofluorescent profiles of CLPs. Gated
Lin cells are analyzed for the expression of
IL-7Ra and Flt3.
(C) The numbers of MPPs, CLPs, pro-B cells,
MEPs, proerythroblasts (pro-E), and GMPs per
two femurs and tibiae. n = 3; *p < 0.05.
(D) RNA content of pro-B cells and MEPs by PY
staining.
(E) Annexin-V staining of pro-B cells.
All error bars represent SD of the mean (A and C).
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Roles of Adipo-osteoprogenitors as the BM Nichemice, consistent with previous studies (Kalaszczynska et al.,
2009; Kozar et al., 2004; Santaguida et al., 2009; Yamazaki
et al., 2006), expression of these genes was markedly reduced
in the HSC population from DT-treated CXCL12-DTR-GFP
mice (Figure 3D and data not shown). In addition, mRNA expres-
sion of the transcriptional repressor Mad1, considered to
decrease cell size (Iritani et al., 2002) and inhibit HSC prolifera-
tion (Walkley et al., 2005), was significantly elevated in the
HSC population from DT-treated CXCL12-DTR-GFP mice (Fig-
ure 3D). Cellular activation by growth factors induces entry
into a phase of cell cycle characterized by initiation of transcrip-
tion and accumulation of RNA, mainly in the form of ribosomal
RNA, which can be measured by RNA-specific dyes, such as
PY. As reported previously, almost all CD34LinSca-1+
c-kit+CD48 HSCs from DT-treated wild-type mice displayed
low PY fluorescence (Figure 3E); however, PY fluorescence
in many HSCs from DT-treated CXCL12-DTR-GFP mice
decreased further compared with wild-type mice (Figure 3E).
Furthermore, in DT-treated CXCL12-DTR-GFP mice, most cells
in the HSC population were smaller than those in control
animals, shown by forward scatter characteristics (FSCs) on
flow cytometry, although Annexin-V staining revealed no
increase in apoptotic cells in the population (Figure 3F and
Figure S3D). Histological analysis of the bone marrow from
DT-treated CXCL12-DTR-GFP mice, in which CAR cells were
severely reduced, revealed that CD150+CD48CD41 HSCs,
which did not adjoin CAR cells, were significantly smaller than
HSCs in contact with the processes of residual CAR cells, indi-
cating that short-term ablation of CAR cells leads to a significant
decrease in the cell size of adjacent HSCs (Figures 3G and 3H).390 Immunity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc.Together, these results indicate that
HSCs are more quiescent in CAR cell-
depleted mice and that CAR cells keep
HSCs in a proliferative state.
Short-Term Ablation of CAR Cells
Induces Early Myeloid
Differentiation of HSCs
It is unclear whether HSC niches regulate
the differentiation of HSCs. To addressthis issue, we analyzed the expression of genes that encode
activities important for HSC differentiation in the HSC population
from CAR cell-depleted mice. It has been shown that elevating
the expression of transcription factor PU.1 in primitive multipo-
tent progenitors induces the generation of myeloid lineage
(Arinobu et al., 2007; DeKoter and Singh, 2000). Of note, qRT-
PCR analysis revealed that the mRNA expression of PU.1
and its macrophage-specific target M-CSF receptor (M-CSFR)
was markedly increased in the CD34LinSca-1+c-kit+CD150+
CD48 HSC population from CXCL12-DTR-GFP mice 2 days
after DT treatment, compared with untreated CXCL12-DTR-GFP
mice or DT-treated and untreated wild-type mice (Figure 3I and
data not shown).
Cells in the HSC population were sorted from bone marrow
of wild-type and CXCL12-DTR-GFP mice 2 days after DT
treatment and cultured in the presence of SCF and CXCL12,
which support myeloid differentiation from HSCs and more
mature multipotent progenitors. Flow-cytometric analysis
showed that substantial numbers of Gr-1hiCD11b+ myeloid
lineage cells were generated from wild-type HSCs at day 10
of culture and peaked at day 14 or later (data not shown). In
contrast, cells in the HSC population from CAR cell-depleted
mice had generated substantial numbers of Gr-1hiCD11b+
myeloid lineage cells earlier, day 7 of culture, and peaked at
day 10, supporting the idea that some cells in the HSC popu-
lation from CAR cell-depleted mice are more differentiated
than in wild-type mice (Figure 3J and data not shown).
Together, these results suggest that short-term CAR cell
depletion prevented HSC maintenance in an undifferentiated
state.
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Figure 3. Essential In Vivo Functional Roles of CAR Cells in HSCs
Bone marrow from wild-type and CXCL12-DTR-GFP mice was analyzed 2 days after DT administration.
(A) Flow-cytometric analysis of the numbers of cells in the CD34LinSca-1+c-kit+CD150+CD48 HSC population per two femurs and tibiae. n = 3; *p < 0.05.
(B) The numbers of HSCs were estimated using repopulating units (RU), based on a competitive repopulation assay. n = 3; *p < 0.05.
(C) Flow-cytometric analysis of the numbers of Ki67-positive cells in the HSC population per two femurs and tibiae. n = 3; *p < 0.05.
(D) Relative mRNA expression levels of Evi-1, Pbx1, Cyclin D1, D2, A2, Cdc2a, Cdc6, and Mad1 in sorted cells in the HSC population by qRT-PCR analysis
normalized to G3PDH levels. n = 4; *p < 0.05.
(E) Flow-cytometric analysis of RNA content of cells in the HSC population by PY staining.
(F) Flow-cytometric analysis of cell size of cells in the HSC population by FSC.
(G and H) Sections of bone marrow from DT-treated CXCL12-DTR-GFP mice were stained with antibodies against CD150, CD48, and CD41. Cell size of
CD150+CD48CD41 HSCs in contact with (G, left) or at a distance from remaining CAR cells (G, right) was determined using a confocal microscope and its
software (H). n = 20; *p < 0.05.
(I) Relative mRNA expression levels of PU.1 andM-CSFR in sorted cells in the HSC population by qRT-PCR analysis normalized to G3PDH levels. n = 4; *p < 0.05.
(J) Generation of myeloid lineage cells from cells in the HSC population in culture at an early point of time. Sorted cells in the HSC population were cultured in the
presence of SCF and CXCL12. Flow-cytometric analysis of the numbers of Gr-1hiCD11b+ cells per input cell at day 7 of culture. n = 4; *p < 0.05. All error bars
represent SD of the mean (A–D and H–J).
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Roles of Adipo-osteoprogenitors as the BM NicheDT Does Not Act Directly on Hematopoietic Cells
in CXCL12-DTR-GFP Mice
To rule out the possibility that DT acted directly on hematopoietic
cells in DT-treated CXCL12-DTR-GFP mice, we infused boneImmarrow cells from CXCL12-DTR-GFP or wild-type mice into
lethally irradiated recipients in the absence of competitor cells.
When bone marrow hematopoietic cells of chimeric mice were
mainly derived from donor HSCs 12 weeks after transplantation,munity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc. 391
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Figure 4. The Phenotypes of Wild-Type
HSCs and Lympho-hematopoietic Progeni-
tors Cultured in Serum Alone
(A) Single CD34LinSca-1+c-kit+CD150+CD48
HSCs, CLPs, pro-B cells, and MEPs from wild-
type mice were sorted and cultured in serum alone
(1 cell/well). The numbers of living cells after 48 hr
culture are shown (green bars). Control samples
before culture have been normalized to 1. n = 3;
*p < 0.05.
(B–D)CD34LinSca-1+c-kit+CD150+CD48HSCs
from wild-type mice were sorted and cultured in
serum alone. QRT-PCR analysis of mRNA expres-
sion of HSC-specific genes (B, upper) and genes
involved in cell-cycle promotion or repression (B,
lower) and early myeloid differentiation (C) in
HSCs before and after 6 hr culture. Results are
expressed as fold difference compared to the
levels found in freshly isolated HSCs from wild-
type mice (G3PDH normalization). n = 3; *p < 0.05.
(D) Left: flow-cytometric analysis of RNA content
of HSCs before (black line) and after (green line)
6 hr culture by PY staining. Right: flow-cytometric
analysis of cell size of HSCs before (black line)
and after (green line) 12 hr culture by PY staining
by FSC. All error bars represent SD of the
mean (A–C).
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Roles of Adipo-osteoprogenitors as the BM Nichewe injected these chimeric mice with 100 ng/kg DT. Flow-
cytometric analysis revealed that the numbers of donor-
derived CD34LinSca-1+c-kit+CD150+CD48 HSCs, CLPs,
pro-B cells, MEPs, proerythroblasts, and GMPs, and the cell
size of donor-derived HSCs in mutant chimeras, were compa-
rable to those observed in control chimeras 2 days after DT treat-
ment (Figures S2B and S3B). These results indicate that a 4-fold
excess of DT does not act directly on CXCL12-DTR-GFP hema-
topoietic cells and that the failure of hematopoiesis in DT-treated
CXCL12-DTR-GFP mice was because of environmental factors.
Phenotypes of HSCs Cultured in Serum Are Similar
to Those from CAR Cell-Depleted Mice
To confirm further the role of bone marrow niches for HSCs and
lymphoid and erythroid progenitors, we sorted CD34LinSca-
1+c-kit+CD150+CD48 HSCs, CLPs, pro-B cells, and MEPs
from bone marrow of wild-type mice and cultured them in serum
alone. After 48 hr of single-cell cultures, many HSCs remained
viable, but the numbers of living CLPs, pro-B cells, and MEPs
were progressively decreased over time (Figure 4A). QRT-PCR
analysis revealed that the mRNA expression of Cyclin D1, D2,
A2, Cdc2a, and Cdc6 was significantly reduced, although the
mRNA expression of Evi-1, Pbx1, and Mad1 was elevated in
the HSC population after 6 hr of culture (Figure 4B). In addition,392 Immunity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc.the mRNA expression of PU.1 and
M-CSFR was markedly increased in the
HSC population cultured in serum alone
(Figure 4C). Flow-cytometric analysis of
cultured HSCs revealed that PY fluores-
cence and the cell size was decreased
compared with freshly isolated HSCs,
although Annexin-V staining revealed nosignificant increase in apoptotic cells (Figure 4D and
Figure S4). Together, these results demonstrate that phenotypes
of wild-type HSCs and lymphoid and erythroid progenitors
cultured in serum alone were similar to those from CAR cell-
depleted bone marrow.
CAR Cells Are the Major Producer of SCF
as Well as CXCL12 in Bone Marrow
To determine the mechanism by which CAR cells support
HSCs and hematopoietic progenitors, we compared the mRNA
expression of SCF and CXCL12, which are essential for the
maintenance of HSCs, CLPs, and B cell and erythroid progeni-
tors (Kohara et al., 2007; Miller et al., 1996; Sugiyama et al.,
2006; Tokoyoda et al., 2004; Waskow et al., 2002), in CAR
cells to other microenvironmental components of bone
marrow. Flow-cytometric analysis of CXCL12-GFP mice has
shown that CAR cells (CXCL12-GFPhiVCAM-1+CD45Ter119)
constitute approximately 0.27% of nucleated cells in the
bone marrow fraction. In the bone fraction, some CD45
Ter119 nonhematopoietic cells have a much lower expression
of CXCL12-GFP relative to CAR cells, and osteopontin (OPN)+
cells have been reported to include osteoblastic niche cells
(Mayack and Wagers, 2008). QRT-PCR analysis of sorted
CAR cells, CD31+Sca-1+CD45Ter119 endothelial cells, and
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Figure 5. Preferential Expression of SCF
and CXCL12 in CAR Cells
(A) QRT-PCR analysis of mRNA expression of
SCF and CXCL12 in sorted CXCL12-GFPhi
CD45Ter119 CAR cells, CD31+Sca-1+CD45
Ter119 endothelial cells (ECs), and CXCL12-
GFPCD31Sca-1CD45Ter119 cells from the
bone marrow fraction and CXCL12-GFPloOPN,
CXCL12-GFPloOPN+, and CXCL12-GFPOPN+
cells from the bone fraction of CXCL12-GFP
mice. Results are expressed as fold difference
compared to the levels found in CAR cell samples
(G3PDH normalization). n = 4.
(B) The amount of SCF and CXCL12 protein per
single femur from wild-type and CXCL12-DTR-
GFP mice at 3 days after DT administration
by enzyme-linked immunosorbent assay (ELISA).
n = 3; *p < 0.05.
(C–E) CD34LinSca-1+c-kit+CD150+CD48HSCs
from wild-type mice were sorted and cultured.
(C) QRT-PCR analysis of mRNA expression of
Cyclin D1, D2, A2, Cdc6, Mad1, and Evi-1 in
HSCs before and after 6 hr culture in serum alone
or with SCF. n = 3; *p < 0.05. (D) Flow-cytometric
analysis of cell size of HSCs cultured in serum
alone (green line) or with SCF (orange line) for
12 hr by FSC. (E) QRT-PCR analysis of mRNA
expression of Cyclin D1 and Mad1 in HSCs before
and after 6 hr culture in serum alone or with
CXCL12. n = 3; *p < 0.05. Results are expressed
as fold difference compared to the levels found
in freshly isolated HSCs (G3PDH normalization)
(C and E).
All error bars represent SD of the mean (A–C
and E).
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Roles of Adipo-osteoprogenitors as the BM NicheCXCL12-GFPCD31Sca-1CD45Ter119 cells from the
bone marrow fraction, and CXCL12-GFPloOPN, CXCL12-
GFPloOPN+, and CXCL12-GFPOPN+ cells from the bone frac-
tion of CXCL12-GFP mice revealed that the expression of SCF
and CXCL12 was considerably higher in CAR cells than in other
populations examined (Figure 5A). Consistent with this, the
protein expression of SCF and CXCL12 was severely reduced
in the bone marrow from CAR cell-depleted mice, supporting
the idea that CAR cells are the major producer of SCF and
CXCL12 in the marrow (Figure 5B). Single-cell RT-PCR analysis
revealed that all individual cells (52 of 52; 100%) within the CAR
cell population expressed SCF in the bone marrow from
CXCL12-GFPmice, suggesting that individual CAR cells express
high amounts of SCF as well as CXCL12. These results are in line
with the facts that SCF augments the proliferation of B cell
and erythroid progenitors in culture (Martin et al., 1990), that
administration of a selective inhibitor (imatinib) of c-kit, c-abl,
and platelet-derived growth factor receptor (PDGFR) tyrosine
kinases led to a reduction in the numbers of CLPs, pro-B cells,
MEPs, and proerythroblasts and to a modest reduction in the
cell size of HSCs (Figure S5), and that the numbers of CLPs,
pro-B cells, and proerythroblasts are severely reduced in mice
lacking SCF receptor c-kit or CAR cells.
Like HSCs from CAR cell-depleted mice, wild-type HSCs
cultured in serum alone revealed altered expression of
genes involved in cell-cycle promotion, DNA replication, and
early myeloid differentiation and had a decreased cell size, asImdescribed above (Figures 4B–4D). SCF completely rescued the
mRNA expression of Cyclin D1, D2, Cdc6, and Mad1 in HSCs
(Figure 5C) and the cell size of HSCs (Figure 5D) in the culture
for 6 hr. In contrast, SCF did not rescue the expression of Cyclin
A2 and downregulated the expression of Evi-1 during SCF treat-
ment (Figure 5C). In contrast, CXCL12 partially rescued the
expression of Cyclin D1 and Mad1 (Figure 5E). These results
suggest that SCF and CXCL12 partially contribute to the niche
functions of CAR cells in HSC maintenance.
Individual CAR Cells Express both Adipogenic
and Osteogenic Genes
We sought to identify the lineage nature of CAR cells. Flow-
cytometric analysis of bone marrow from CXCL12-GFP mice
revealed that CXCL12-GFPhi CAR cells exhibited a largely homo-
geneous expression of cell-surface proteins, including VCAM-1,
CD44, CD51 (av integrin), PDGFRa and PDGFRb, suggesting
that CAR cells consist of a relatively homogeneous population
(Figure S6A). We analyzed mRNA expression of lineage-specific
markers in sorted non-hematopoietic cell populations from the
bone marrow and bone fractions of CXCL12-GFP mice. QRT-
PCR analysis has shown that the expressions of C/EBPa and
peroxisome proliferator-activated receptor g (PPARg), which
are essential for adipocyte differentiation (Barak et al., 1999),
and Runx2 and Osterix, which are essential for osteogenic
progenitors (Komori et al., 1997; Nakashima et al., 2002), were
considerably higher in CAR cells than in other populationsmunity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc. 393
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Figure 6. Expression of Requisite Factors for Adipogenesis and
Osteogenesis in CAR Cells
(A) QRT-PCR analysis of sorted CXCL12-GFPhiCD45Ter119 CAR cells,
CD31+Sca-1+CD45Ter119 endothelial cells (ECs), and CXCL12-GFP
CD31Sca-1CD45Ter119 cells from the bone marrow fraction and
CXCL12-GFPloOPN, CXCL12-GFPloOPN+, and CXCL12-GFPOPN+ cells
from the bone fraction of CXCL12-GFPmice. mRNA levels of C/EBPa, PPARg,
Runx2, Osterix, Col1a1, and Osteocalcin. CAR cell samples have been
normalized to 1. Error bars represent SD of the mean; n = 4.
(B) Single-cell RT-PCR analysis of the frequency of cells expressing PPARg,
Runx2, and Osterix in sorted CAR cells. n = 2.
(C) Bone marrow sections from 14-week-old CXCL12-GFP mice stained with
antibodies against PPARg (red). Most CAR cells (green) express PPARg
(yellow).
(D) Bone marrow sections from 3-week-old growing CXCL12-GFP mice
stained with antibodies against Osterix (red). Most CAR cells (green) express
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osteocalcin, which are abundant in osteoblasts, wasmuch lower
in CAR cells than in CXCL12-GFPloOPN+ or CXCL12-GFPlo
OPN cells from the bone fraction (Figure 6A). Furthermore, we
observed a higher expression of BMPRIA and PPR, which
regulate bone formation and HSC niche function (Calvi et al.,
2003; Zhang et al., 2003), in CAR cells than in other cell popula-
tions (Figure S6B). To address the possibility that distinct adipo-
genic and osteogenic progenitors are included in the CAR cell
population, we analyzed the expression of adipogenic and
osteogenic genes in CAR cells at the single-cell level. Single-
cell RT-PCR analysis revealed that most or all individual cells
within the CAR cell population expressed PPARg, Runx2, and
Osterix in bone marrow from CXCL12-GFP mice, suggesting
that most CAR cells are adipo-osteogenic bipotential progeni-
tors (Figure 6B). Consistent with this, immunohistochemical
analysis of bonemarrow revealed thatmost CAR cells expressed
PPARg protein (Figure 6C). In addition, Osterix protein expres-
sionwas observed inmanyCAR cells aswell as bone-lining oste-
oblasts in 3-week-old growing CXCL12-GFP mice (Figure 6D
and data not shown).
Individual CAR Cells Have Potential to Differentiate
into Adipocytic and Osteoblastic Cells
We analyzed the ability of CAR cells to differentiate into adipo-
cytic and osteoblastic cells in vitro. When CAR cells were sorted,
most of these cells died immediately in culture. Thus, we cultured
whole bone marrow cells from CXCL12-GFP mice in medium
containing a PPARg activator, pioglitazone. In the cultures,
most CXCL12-GFP+ CAR cells appeared to remain viable and
manyCAR cells (63%) differentiated intomultivacuolar lipid-con-
taining preadipocytes, as assessed by Nile Red staining (Figures
7A and 7B), suggesting that the majority of CAR cells have the
potential to differentiate into adipocytic cells in vitro. Subse-
quently, we cultured whole bone marrow cells from CXCL12-
GFPmice in the presence of BMP-2 and analyzed the expression
of an osteoblast differentiation-related marker, ALP, in individual
CAR cells. In the cultures, most CAR cells appeared to remain
viable, and the majority of CAR cells (90%) exhibited high ALP
activity (Figure 7C and Figure S7). Because histological analysis
of bone marrow has shown that only bone-lining mature osteo-
blasts exhibited high ALP activity (Figure 1C), these results
suggest that most CAR cells have potential to differentiate into
mature osteoblasts.
Next, we analyzed the ability of CAR cells to differentiate into
adipocytic cells in vivo. It has been shown previously that multi-
vacuolar lipid-containing precursors of adipocytes appear in the
bone marrow of humans and mice in the early aplastic phase
following chemotherapy (Bianco et al., 1988). We injected
CXCL12-GFP mice with 250 mg/kg of 5-fluorouracil (5-FU),
which preferentially eliminates proliferating cells. Multivacuolar
lipid-containing CAR cells, as assessed by Nile Red staining,
were observed in the bone marrow 7 days after 5-FU injection
(Figure 7D). Some of these multivacuolar lipid-containing CAR
cells surrounded sinusoidal endothelial cells, and others didOsterix (yellow). In (C) and (D), the nuclei of cells were labeled with DAPI dye
(blue); S, vascular sinus.
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Figure 7. CAR Cells Have the Potential to
Differentiate into Adipocytic and Osteo-
blastic Cells
(A-C) Bone marrow cells from CXCL12-GFP mice
were cultured with pioglitazone (A and B) or
BMP-2 (C). (A and B) After 7 days, cultures were
analyzed by Nile Red staining. (A) Lipid inclusions
(red) within the cytoplasm of CAR cells (green).
(B) Frequency of lipid-containing cells in the whole
CAR cells. (C) After 4 days, ALP activity was
assayed by Fast Red staining. Frequency of ALP
activity-containing cells in whole CAR cells.
(D and E) CXCL12-GFPmice were analyzed 7 days
after administration of 5-FU or control vehicle. (D)
Bone marrow sections stained with Nile Red. Lipid
inclusions (arrows; red) within the cytoplasm of
some CAR cells (green). (E) Single-cell RT-PCR
analysis of the frequency of cells expressing aP2
(left) and perilipin (right) in sorted CAR cells.
(F) The bone marrow sections from 3-week-old
growing CXCL12-GFP mice. Some CAR cells
(green) are in contact with (arrowheads) or inserted
into (arrow) the layer of mature osteoblasts lining
the bone surface.
(G and H) Whole bone marrow cells from wild-type
and CXCL12-DTR-GFP mice at 2 days after DT
administration were cultured with pioglitazone (G)
or BMP-2 (H). (G) After 7 days, cultures were
analyzed by Nile Red staining. Numbers of lipid-
containing cells are shown. (H) After 4 days, ALP
activity was assayed by Fast Red staining. The
percentage of the ALP-positive area relative to
the culture area is shown. All error bars represent
SD of the mean; n = 4; *p < 0.05 (B, C, E, G and
H). The nuclei of cells were labeled with DAPI
dye (blue) (D and F).
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Roles of Adipo-osteoprogenitors as the BM Nichenot (Figure 7D). Additionally, single-cell RT-PCR analysis
revealed that the frequencies of cells expressing aP2, an adipo-
cyte-specific fatty acid binding protein, and perilipin, a protein
coating lipid droplets of adipocytes, which is essential for
adipogenesis (Martinez-Botas et al., 2000) within CAR cells,
were elevated from 17% and 0.49% in untreated mice to 87%
and 16% in mice 7 days after 5-FU injection, respectively
(Figure 7E), suggesting that some CAR cells differentiated into
adipocytes in vivo after 5-FU-induced bone marrow hypoplasia.
In addition, immunohistochemical analysis of 3-week-old
growing CXCL12-GFP mice has shown that some CAR cells
are in contact with or inserted into the layer of CXCL12-GFP
mature osteoblasts lining the bone surface, raising the possibility
that CAR cells near the bone surface differentiate into mature
osteoblasts in vivo (Figure 7F). Together, these results suggest
that the majority of CAR cells have the potential to differentiate
into adipocytic and osteoblastic cells, and the differentiation of
some CAR cells occurs in vivo.
Finally, we analyzed the ability of CAR cell-depleted bone
marrow cells to differentiate into adipocytic and osteoblasticImmunity 33, 387–399, Secells. We cultured whole bone marrow
cells from DT-treated CXCL12-DTR-GFP
mice and control animals in medium
containing pioglitazone or BMP-2. The
numbers of lipid-containing adipocyticcells or marked ALP activity-containing osteoblastic cells were
severely reduced in cultures from CAR cell-depleted bone
marrow cells compared with cultures from control bone marrow
cells, as assessed by Nile Red or Fast Red staining, respectively
(Figures 7G and 7H and data not shown). These results support
the idea that CAR cells are progenitors of adipocytes and oste-
oblasts within bone marrow.
DISCUSSION
In this study, we determined the in vivo essential role of CAR cells
as the niche for HSCs and lymphoid and erythroid progenitors,
using DT-treated CXCL12-DTR-GFP mice in which CAR cells
were selectively lost but other candidate niches, including
bone-lining osteoblasts, SNO cells, and endothelial cells, were
still present. Together with the significant mRNA expression of
Col1a1 in CAR cells, there is a possibility that CAR cells were
decreased in the Col2.3DTK mice depleted of cells with the rat
Col1a1 gene promoter driving thymidine kinase, in which B cells
and erythrocytes were reduced (Visnjic et al., 2004). In addition,ptember 24, 2010 ª2010 Elsevier Inc. 395
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Roles of Adipo-osteoprogenitors as the BM Nichebecause CAR cells exhibited high expression of BMPRIA and
PPR, which have been reported to control HSC numbers,
BMPRIA and/or PPRmight regulate niche functions of CAR cells.
HSCs remained viable much longer than lymphoid and
erythroid progenitors during cultures in serum alone and
display similar phenotypes to HSCs from CAR cell-depleted
mice. Considering that serum contains widely diffusible signals
present in the circulation and marrow non-niche microenviron-
ment, these results suggest that CAR cells are the major
producer of specific niche signals for HSCs and hematopoietic
progenitors in bone marrow. Because our results indicate
that CAR cells are the major producer of SCF and CXCL12,
which are essential for the maintenance of HSCs and lymphoid
and erythroid progenitors, SCF and CXCL12 would contribute
in concert with other factors to the niche functions of CAR cells.
Recent studies using label-retaining assays have identified
a highly dormant small subpopulation (30%) of HSCs, termed
dormant HSCs (d-HSCs), dividing about every 145 days, and
another rarely dividing activated HSC (a-HSCs) subpopulation
(70%) dividing around every 36 days, within the CD34Lin
Sca-1+c-kit+CD150+CD48 HSC population of bone marrow
(Wilson et al., 2008). Considering that HSCs were reduced and
more quiescent in the absence of CAR cells, this raises the
possibility that a-HSCs were selectively lost or returned to
a d-HSC status in CAR cell-depleted mice. Further studies will
be needed to determine the role of CAR cells in the maintenance
of d-HSCs and a-HSCs.
Our findings suggest that CAR cells maintain both HSCs
and B cell and erythroid progenitors in a proliferative state;
however, HSCs are cycling slowly, although B cell and erythroid
progenitors are cycling much more rapidly. How can we
explain the difference? Infrequent division of HSCs may be
controlled byHSC-intrinsic mechanisms. An alternative explana-
tion is that CAR cells or other microenvironmental components
located near CAR cells, including endothelial cells, provide
signals that slow the proliferation of HSCs, but not lymphoid
or erythroid progenitors. Candidates include Angiopoietin-1,
Wnts, and TGF-bs, which have been reported to slow the
proliferation of HSCs (Arai et al., 2004; Fleming et al., 2008;
Yamazaki et al., 2009). In contrast, critical lineage-specific
soluble factors, including IL-7 and erythropoietin, augment the
proliferation of lymphoid and erythroid progenitors, respectively,
but not HSCs.
Although niche signals maintain stem cells in an undifferenti-
ated state in Drosophila gonads (Xie and Spradling, 1998), it
remains unclear whether vertebrate HSC niches employ an
analogous mechanism. Our findings that HSCs from CAR cell-
depleted mice have a markedly increased mRNA expression of
PU.1 and generate substantial numbers of myeloid lineage cells
in culture earlier than the wild-type suggest that CAR cells keep
HSCs in an undifferentiated state. It may be that myeloid differ-
entiation of HSCs is a default pathway in the absence of niche
signals that maintain HSCs in a proliferative state. Alternatively,
CAR cells may provide signals which inhibit the myeloid differen-
tiation of HSCs controlled by non-CAR cell microenvironmental
factors and/or HSC-intrinsic mechanisms.
At 2 days after the induction of CAR cell ablation, the numbers
of HSCs were reduced about 50% in the marrow. Because it has
been reported that only about 4% of HSCs are proliferating at396 Immunity 33, 387–399, September 24, 2010 ª2010 Elsevier Inc.any given time (Kiel et al., 2005) and that HSCs divide every 36
or 145 days (Wilson et al., 2008), HSC reduction over 2 days in
CAR cell-depleted mice cannot be explained simply by the
results that CAR cells maintain HSCs in a proliferative state. It
is likely that enhanced differentiation of some HSCs caused
HSC reduction in CAR cell-depleted mice. In addition, although
no increase in Annexin-V-positive apoptotic cells in the HSC
fraction and the accumulation of HSCs in the circulation was
observed in CAR cell-depleted mice, there is a possibility that
CAR cells are also involved in supporting the survival and/or
retention of HSCs within bone marrow.
CXCL12-DTR-GFPmice died probably from liver failure 5 days
after DT treatment and it should also be noted that thrombopoie-
tin (TPO), which plays a critical role in hematopoiesis is predom-
inantly expressed in liver (Lok et al., 1994). However, at 2 days
after DT treatment, the liver of CXCL12-DTR-GFP mice in which
bone marrow hematopoiesis was affected appeared normal
macroscopically and histologically, and had normal expression
of TPO mRNA by qRT-PCR analysis (data not shown). In addi-
tion, there was no reduction of TPO protein in peripheral blood
of the DT-treated CXCL12-DTR-GFP mice (data not shown).
These results suggest that the liver of CXCL12-DTR-GFP mice
did not cause the hematopoietic abnormalities 2 days after DT
treatment. On the other hand, in the bone marrow of DT-treated
CXCL12-DTR-GFPmice in which the numbers of CAR cells were
reduced, the size of HSCs in contact with the remaining CAR
cells was normal, although the size of HSCs which did not adjoin
CAR cells was significantly reduced by histological analysis.
Together, it is likely that phenotypes observed in the marrow of
CXCL12-DTR-GFP mice were because of loss of CAR cells
2 days after DT treatment.
Our results do not rule out the possibility that other candidate
niches, including SNO cells and endothelial cells, play an impor-
tant role in hematopoiesis. The results that the numbers of
MPPs, CCR9+MPPs, and CD122+NK1.1 NK progenitors were
normal, although CLPs and CCR9+CLPs (Zlotoff et al., 2010)
were reduced in DT-treated CXCL12-DTR-GFP mice (Fig-
ure S2C), suggest that progenitors for distinct lymphoid lineages
may inhabit different niches and have different requirements
in bonemarrow. BecausemanyCAR cells are perivascular, inter-
action betweenCAR cells and endothelial cells may be important
in the construction of HSC niches. Experiments using mice
that allow the selective depletion of SNO cells or sinusoidal
endothelial cells will be needed to determine the niche functions
of these cells.
We have suggested that CAR cells are adipo-osteogenic
progenitors, which produce large amounts of hematopoietic
cytokines, CXCL12 and SCF, before they differentiate into
mature cells producing large amounts of proteins for the storage
of nutritional energy or bone formation. Previous studies have
shown that adventitial reticular cells covering the endothelium
of vascular sinuses give rise to adipocytes (Bianco et al., 1988)
and that osteogenic progenitors are present in the intertrabecu-
lar space of bone marrow (Rouleau et al., 1990). Our results
explain this discrepancy and suggest an essential in vivo role
of adipo-osteogenic progenitors in bone marrow. In addition,
our findings raise the possibility that differentiation of CAR cells
into adipocytic and/or osteoblastic cells alters their niche func-
tions. Together, our findings provide a basis for understanding
Immunity
Roles of Adipo-osteoprogenitors as the BM Nichehow microenvironmental niches regulate HSC maintenance and
lympho-hematopoiesis within bone marrow.
EXPERIMENTAL PROCEDURES
Mice
CXCL12-GFP mice (Ara et al., 2003) and CXCL12-DTR-GFP mice were main-
tained on a C57BL/6 background. 5-FU (Kyowa Hakko Kirin) was injected
intraperitoneally into 12- to 15-week-old mice. Imatinib (Glivec; Novartis)
was applied by oral gavage (twice a day, 200 mg/kg/day). All experiments
were performed under guidelines of the animal ethics committee of Institute
for Frontier Medical Sciences, Kyoto University.
Generation of CXCL12-DTR-GFP Mice
The targeting vector was generated as shown in Figure 1A. The neo cassette
was removed from the recombinant allele by Cre-recombinase in vivo.
CXCL12-DTR-GFP mice were backcrossed to C57BL/6 mice six times. DT
(MBL) was injected intraperitoneally into 12- to 15-week-old mice.
Antibodies
The antibodies used were described in Supplemental Experimental Proce-
dures.
Flow-Cytometric Analysis and Cell Sorting
Cell-cycle analysis was performed as described in our previous publication
(Sugiyama et al., 2006). For the apoptosis assay, Annexin V-FITC Apoptosis
Detection Kit I (BD Biosystems) was used according to the manufacturer’s
instruction. All flow-cytometric experiments and cell sorting were performed
using a BD FACSAria (BD Biosystems). For sorting the nonhematopoietic
cell populations, cells in bone marrow fraction were obtained from femurs
and tibiae by flushing and collagenase (Sigma) digestion, and cells in bone
fraction were obtained frommarrow-depleted bones bymechanical disruption
and collagenase digestion (Mayack and Wagers, 2008).
Competitive Repopulation Assay
Unfractionated 1/20 of bone marrow cells from two femurs and tibiae (C57BL/
6-Ly5.2+ background) to be tested were mixed with 13 106 bonemarrow cells
of C57BL/6-Ly5.1+mice as competitor cells andwere transplanted into lethally
irradiated (9 Gy) C57BL/6-Ly5.1+ mice. Peripheral blood cells of the recipient
mice were taken 12 weeks after transplantation, and myeloid cells were
analyzed by flow cytometer because their high turnover provides a good
measure of HSC activity. Repopulating Units (RU) were calculated using Har-
rison’s formula as described previously (Harrison et al., 1993).
Cell Culture and Analysis
For stromal cell-free culture, cells were sorted from wild-type mice and
cultured in RPMI-1640 medium (Invitrogen) or S clone SF-3 medium (Sanko
Junyaku) containing 10% fetal calf serum (FCS) with or without 20 ng/ml
SCF (R&D Systems) or 1 mg/ml CXCL12. Cultured PI viable cells were re-
sorted and analyzed.
For adipogenic differentiation, bone marrow cell suspensions were cultured
on a collagen-coated dish in DMEM supplemented with pioglitazone (Takeda
Pharmaceutical) (10 mM), 10% FCS, and 53 105 M 2-b-mercaptoethanol for
7 days. To visualize lipid droplets, PFA fixation and Nile Red staining were per-
formed. For osteogenic differentiation, bone marrow cell suspensions were
cultured in a-MEM supplemented with BMP-2 (R&D Systems) (300 ng/ml),
10% FCS, and 5 3 105 M 2-b-mercaptoethanol for 4 days. Osteoblastic
phenotypes were evaluated by the activity of ALP using Fast Red staining.
Immunohistochemical Analysis
Bone marrow sections were analyzed by immunofluorescence as described
previously (Sugiyama et al., 2006). To visualize lipid droplets, Nile Red staining
was performed. Confocal microscopy was performed with a LSM 510 META
(Carl Zeiss).
QRT-PCR Analysis
Total RNA was isolated from sorted cells using Isogen (Nippon Gene) and
treated with DNase I (Invitrogen). cDNA was synthesized using SuperScriptImVILO (Invitrogen) following the manufacturer’s instructions. QRT-PCR analysis
was performed with a Step One Plus (Applied Biosystems) using Power SYBR
Green PCR Master Mix (Applied Biosystems). Values for each gene were
normalized to the relative quantity of Gapdh mRNA in each sample. The
primers used for PCR are listed in Supplemental Experimental Procedures.
Single-Cell RT-PCR Analysis
Single cells were sorted into reverse transcription buffer containing 1 U/ml
RNase Inhibitor (Toyobo) and 0.4% Nonidet P-40 (Nacalai Tesque) using
flow cytometry. Cell lysates were reverse-transcribed using M-MLV reverse
transcriptase (Toyobo) and gene-specific reverse primers. PCR was per-
formed by the addition of premixed hot-start PCR enzymes and buffers
(AmpliTaq Gold; Applied Biosystems) containing the gene-specific forward
and reverse primers designed to span introns to exclude genomic products.
PCR was carried out in one round with 50 amplification cycles. The primers
used for PCR are listed in Supplemental Experimental Procedures.
ELISA
Femurs were flushed with 0.3 ml of PBS containing a protease inhibitor cock-
tail (Sigma) and Nonidet P40 (1%). Cells were lysed by freeze and thaw, and
the cell debris was removed by centrifugation and discarded. The concentra-
tions of SCF and CXCL12 were measured using DuoSet ELISA Development
kits (R&D Systems) according to the manufacturer’s instructions.
Statistical Analysis
The significance of the difference between groups in the experiments was
evaluated by analysis of variance followed by a two-tailed Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.immuni.2010.08.017.
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